Sen. Rick Scott (R-Fla.) on Thursday unveiled legislation that would require prescription drug labels to include information ...
Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
FDA requests information to explore whether current gluten labeling rules adequately protect consumers, with implications for ...
The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
As the FDA moves to finalize a rule requiring front-of-package (FOP) nutrition labels on most packaged foods and beverages in ...
The FDA approved a new drug application labeling supplement that allows readministration of iDose TR with a repeat treatment ...
The Supreme Court on Jan. 16, 2026, agreed to decide a case about how generic companies can communicate to the market about their products, ...
On January 16, 2026, the U.S. Supreme Court announced its intent to hear the case of Hikma v. Amarin. This case follows the landmark GSK v. Teva ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...
Results from the iDose TR exchange trial showed a second administration and removal of the original implant was safe and well tolerated over 12 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results